New hope for tough myeloma: Two-Drug combo targets genetic weakness
NCT ID NCT05853965
First seen May 21, 2026 · Last updated Jun 16, 2026 · Updated 5 times
Summary
This study tests a combination of two drugs, belantamab mafodotin and venetoclax, with or without dexamethasone, in people whose multiple myeloma has returned and is hard to treat. The cancer must have a specific genetic change called t(11;14). The goal is to find the safest and most effective dose and see how well the treatment controls the disease. About 45 adults will take part.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MULTIPLE MYELOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Email: •••••@•••••
Locations
-
Klinikum Chemnitz
RECRUITINGChemnitz, Germany
Contact Email: •••••@•••••
-
UKSH Lübeck
RECRUITINGLübeck, Germany
Contact Email: •••••@•••••
-
Uniklinik Heidelberg
RECRUITINGHeidelberg, Germany
Contact Email: •••••@•••••
-
Uniklinkum Ulm
RECRUITINGUlm, Germany
Contact Email: •••••@•••••
-
University Medical Center Hamburg-Eppendorf
RECRUITINGHamburg, Ham, 20246, Germany
Contact
Contact
Conditions
Explore the condition pages connected to this study.